LncRNA AC007255.1, an immune-related prognostic enhancer RNA in esophageal cancer

LncRNA AC007255.1, an immune-related prognostic enhancer RNA in esophageal cancer

Background Growing evidence has suggested that enhancer RNAs (eRNAs), a set of long non-coding RNAs (lncRNAs) that were derived from active enhancer regions, play critical roles in regulating gene expression in human cancers. Nevertheless potential functions of eRNAs in esophageal cancer ESCA have n...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Qingqing Wang, Xiaoyan Yu, Ningning Yang, Lu Xu, Yunfeng Zhou
Natura:	Articolo
Lingua:	English
Pubblicazione:	PeerJ Inc. 2021-07-01
Serie:	PeerJ
Soggetti:	Esophageal cancer AC007255.1 PRR15 Enhancer RNA Prognosis Immune infiltration
Accesso online:	https://peerj.com/articles/11698.pdf

Documenti analoghi

Exploration of the relationship between ACLY and esophageal cancer based on bioinformatics and related experiments
di: Meng WANG, et al.
Pubblicazione: (2023-10-01)

An anoikis-related lncRNA signature may predict the prognosis, immune infiltration, and drug sensitivity in esophageal cancer
di: Fan Feng, et al.
Pubblicazione: (2024-05-01)

LncRNA AC100826.1 regulated PLCB1 to promote progression in non‐small cell lung cancer
di: Shenhui Dai, et al.
Pubblicazione: (2024-07-01)

Identification of a novel prognostic cuproptosis-associated LncRNA signature for predicting prognosis and immunotherapy response in patients with esophageal cancer
di: Xinhai Sun, et al.
Pubblicazione: (2024-05-01)

PRR13 expression as a prognostic biomarker in breast cancer: correlations with immune infiltration and clinical outcomes
di: Mingjing Meng, et al.
Pubblicazione: (2025-03-01)

LncRNA-AC02278.4 Is a Novel Prognostic Biomarker That Promotes Tumor Growth and Metastasis in Lung Adenocarcinoma
di: Xi Chen, et al.
Pubblicazione: (2022-04-01)

Corrigendum: LncRNA-AC02278.4 is a novel prognostic biomarker that promotes tumor growth and metastasis in lung adenocarcinoma
di: Xi Chen, et al.
Pubblicazione: (2024-03-01)

A methylation‐related lncRNA‐based prediction model in lung adenocarcinomas
di: Kun Yang, et al.
Pubblicazione: (2024-08-01)

A novel disulfidptosis-related LncRNA prognostic risk model: predicts the prognosis, tumor microenvironment and drug sensitivity in esophageal squamous cell carcinoma
di: Chunlin Ye, et al.
Pubblicazione: (2024-11-01)

Identification of m6A/m5C-related lncRNA signature for prediction of prognosis and immunotherapy efficacy in esophageal squamous cell carcinoma
di: Jianlin Wang, et al.
Pubblicazione: (2024-04-01)

The Interaction of lncRNA-HEIH and lncRNA-HULC with HBXIP in Hepatitis B Patients
di: Lingjuan Ruan, et al.
Pubblicazione: (2018-01-01)

A methylation- and immune-related lncRNA signature to predict ovarian cancer outcome and uncover mechanisms of chemoresistance
di: Lu Chen, et al.
Pubblicazione: (2023-09-01)

LncRNA Expression Profile-Based Matrix Factorization for Predicting lncRNA- Disease Association
di: Jihwan Ha
Pubblicazione: (2024-01-01)

Glycerol kinase enzyme is a prognostic predictor in esophageal carcinoma and is associated with immune cell infiltration
di: Fei Ying, et al.
Pubblicazione: (2024-02-01)

Expression profiling of circulating lncRNA GIAT4RA, lncRNA AATBC, lncRNA Sirt1-AS, and SMARCB1 in lung cancer patients
di: Neveen A. Hussein, et al.
Pubblicazione: (2024-09-01)

Integrated analysis of lymphocyte infiltration-associated lncRNA for ovarian cancer via TCGA, GTEx and GEO datasets
di: Meijing Wu, et al.
Pubblicazione: (2020-05-01)

Corrigendum: A novel LncRNA, AC091729.7 promotes sinonasal squamous cell carcinomas proliferation and invasion through binding SRSF2
di: Boyu Yu, et al.
Pubblicazione: (2024-09-01)

LncRNA FOXD3-AS1 Promotes the Malignant Progression of Nasopharyngeal Carcinoma Through Enhancing the Transcription of YBX1 by H3K27Ac Modification
di: Huiyun Yang, et al.
Pubblicazione: (2021-07-01)

Establishment of a prognostic risk prediction model incorporating disulfidptosis-related lncRNA for patients with prostate cancer
di: Yelisudan Mulati, et al.
Pubblicazione: (2024-01-01)

Immune cell‐related prognostic risk model and tumor immune environment modulation in esophageal carcinoma based on single‐cell and bulk RNA sequencing
di: Xiao Wen, et al.
Pubblicazione: (2024-05-01)

Novel pyroptosis-immune-related lncRNA signature exhibits a distinct immune cell infiltration landscape in breast cancer
di: Dedi Kong, et al.
Pubblicazione: (2025-01-01)

Corrigendum: LncRNA FOXD3-AS1 promotes the malignant progression of nasopharyngeal carcinoma through enhancing the transcription of YBX1 by H3K27Ac modification
di: Huiyun Yang, et al.
Pubblicazione: (2024-06-01)

Comprehensive analysis of lncRNA biomarkers in kidney renal clear cell carcinoma by lncRNA-mediated ceRNA network.
di: Ke Gong, et al.
Pubblicazione: (2021-01-01)

lncRNA in HNSCC: challenges and potential
di: Kacper Guglas, et al.
Pubblicazione: (2017-12-01)

LncRNA-encoded peptides in cancer
di: Yaguang Zhang
Pubblicazione: (2024-08-01)

lncRNA Biomarkers of Glioblastoma Multiforme
di: Markéta Pokorná, et al.
Pubblicazione: (2024-04-01)

Identification of an Oxidative Stress-Related LncRNA Signature for Predicting Prognosis and Chemotherapy in Patients With Hepatocellular Carcinoma
di: Zixuan Zhong, et al.
Pubblicazione: (2022-10-01)

Construction of a novel disulfidptosis and cuproptosis-related lncRNA signature for predicting the clinical outcome and immune response in stomach adenocarcinoma
di: Caihao Qu, et al.
Pubblicazione: (2025-02-01)

Mechanism study of lncRNA RMRP regulating esophageal squamous cell carcinoma through miR-580-3p/ATP13A3 axis
di: ZiRui Tan, et al.
Pubblicazione: (2024-05-01)

Integrative analysis of dysregulated lncRNA-associated ceRNA network reveals potential lncRNA biomarkers for human hepatocellular carcinoma
di: Chengyun Li, et al.
Pubblicazione: (2020-03-01)

Novel insights into post-marketing adverse events associated with lenvatinib: A comprehensive analysis utilizing the FAERS database
di: Zhe Yu, et al.
Pubblicazione: (2024-03-01)

A genome‐wide analysis of long noncoding RNA profile identifies differentially expressed lncRNAs associated with Esophageal cancer
di: Wenjia Liu, et al.
Pubblicazione: (2018-08-01)

The Esophageal Microbiota in Esophageal Health and Disease
di: Erica Bonazzi, et al.
Pubblicazione: (2024-11-01)

Knockdown of LncRNA-HAGLR restrains the viability and motility of pancreatic cancer via miR-625-5p/TAF15 axis in vitro and in vivo
di: Jiafu Wang, et al.
Pubblicazione: (2024-09-01)

Integrating bioinformatics and machine learning to uncover lncRNA LINC00269 as a key regulator in Parkinson's disease via pyroptosis pathways
di: LiLi Ma, et al.
Pubblicazione: (2024-12-01)

Identification of a DNA damage repair-related LncRNA signature for predicting the prognosis and immunotherapy response of hepatocellular carcinoma
di: Fei Huang, et al.
Pubblicazione: (2024-02-01)

The expression regulation and clinical significance of miRNA in esophageal cancer
di: Ya-Nan LI, et al.
Pubblicazione: (2021-12-01)

The role of lncRNA and miRNA in the pathogenesis of renal fibrosis
di: Liang CHANG, et al.
Pubblicazione: (2023-04-01)

lncRNA-mediated ceRNA network in bladder cancer
di: Kun Li, et al.
Pubblicazione: (2023-06-01)

The sound of silent RNA in tuberculosis and the lncRNA role on infection
di: Eduardo Fukutani Rocha, et al.
Pubblicazione: (2024-01-01)